Metabolomic screening of regional brain alterations in the APP/PS1 transgenic model of Alzheimer's disease by direct infusion mass spectrometry
•Direct infusion mass spectrometry allows a comprehensive brain metabolomic analysis.•The APP/PS1 mice exhibited an abnormal neurochemical profile compared to controls.•These failures affected hippocampus, cortex, cerebellum and olfactory bulbs.•Pathway analysis revealed multiple significant impairm...
Saved in:
Published in | Journal of pharmaceutical and biomedical analysis Vol. 102; pp. 425 - 435 |
---|---|
Main Authors | , , , |
Format | Journal Article |
Language | English |
Published |
England
Elsevier B.V
05.01.2015
|
Subjects | |
Online Access | Get full text |
ISSN | 0731-7085 1873-264X 1873-264X |
DOI | 10.1016/j.jpba.2014.10.009 |
Cover
Loading…
Abstract | •Direct infusion mass spectrometry allows a comprehensive brain metabolomic analysis.•The APP/PS1 mice exhibited an abnormal neurochemical profile compared to controls.•These failures affected hippocampus, cortex, cerebellum and olfactory bulbs.•Pathway analysis revealed multiple significant impairments in brain metabolism.
The identification of pathological mechanisms underlying to Alzheimer's disease is of great importance for the discovery of potential markers for diagnosis and disease monitoring. In this study, we investigated regional metabolic alterations in brain from the APP/PS1 mice, a transgenic model that reproduces well some of the neuropathological and cognitive deficits observed in human Alzheimer's disease. For this purpose, hippocampus, cortex, cerebellum and olfactory bulbs were analyzed using a high-throughput metabolomic approach based on direct infusion mass spectrometry. Metabolic fingerprints showed significant differences between transgenic and wild-type mice in all brain tissues, being hippocampus and cortex the most affected regions. Alterations in numerous metabolites were detected including phospholipids, fatty acids, purine and pyrimidine metabolites, acylcarnitines, sterols and amino acids, among others. Furthermore, metabolic pathway analysis revealed important alterations in homeostasis of lipids, energy management, and metabolism of amino acids and nucleotides. Therefore, these findings demonstrate the potential of metabolomic screening and the use of transgenic models for understanding pathogenesis of Alzheimer's disease. |
---|---|
AbstractList | The identification of pathological mechanisms underlying to Alzheimer's disease is of great importance for the discovery of potential markers for diagnosis and disease monitoring. In this study, we investigated regional metabolic alterations in brain from the APP/PS1 mice, a transgenic model that reproduces well some of the neuropathological and cognitive deficits observed in human Alzheimer's disease. For this purpose, hippocampus, cortex, cerebellum and olfactory bulbs were analyzed using a high-throughput metabolomic approach based on direct infusion mass spectrometry. Metabolic fingerprints showed significant differences between transgenic and wild-type mice in all brain tissues, being hippocampus and cortex the most affected regions. Alterations in numerous metabolites were detected including phospholipids, fatty acids, purine and pyrimidine metabolites, acylcarnitines, sterols and amino acids, among others. Furthermore, metabolic pathway analysis revealed important alterations in homeostasis of lipids, energy management, and metabolism of amino acids and nucleotides. Therefore, these findings demonstrate the potential of metabolomic screening and the use of transgenic models for understanding pathogenesis of Alzheimer's disease.The identification of pathological mechanisms underlying to Alzheimer's disease is of great importance for the discovery of potential markers for diagnosis and disease monitoring. In this study, we investigated regional metabolic alterations in brain from the APP/PS1 mice, a transgenic model that reproduces well some of the neuropathological and cognitive deficits observed in human Alzheimer's disease. For this purpose, hippocampus, cortex, cerebellum and olfactory bulbs were analyzed using a high-throughput metabolomic approach based on direct infusion mass spectrometry. Metabolic fingerprints showed significant differences between transgenic and wild-type mice in all brain tissues, being hippocampus and cortex the most affected regions. Alterations in numerous metabolites were detected including phospholipids, fatty acids, purine and pyrimidine metabolites, acylcarnitines, sterols and amino acids, among others. Furthermore, metabolic pathway analysis revealed important alterations in homeostasis of lipids, energy management, and metabolism of amino acids and nucleotides. Therefore, these findings demonstrate the potential of metabolomic screening and the use of transgenic models for understanding pathogenesis of Alzheimer's disease. The identification of pathological mechanisms underlying to Alzheimer's disease is of great importance for the discovery of potential markers for diagnosis and disease monitoring. In this study, we investigated regional metabolic alterations in brain from the APP/PS1 mice, a transgenic model that reproduces well some of the neuropathological and cognitive deficits observed in human Alzheimer's disease. For this purpose, hippocampus, cortex, cerebellum and olfactory bulbs were analyzed using a high-throughput metabolomic approach based on direct infusion mass spectrometry. Metabolic fingerprints showed significant differences between transgenic and wild-type mice in all brain tissues, being hippocampus and cortex the most affected regions. Alterations in numerous metabolites were detected including phospholipids, fatty acids, purine and pyrimidine metabolites, acylcarnitines, sterols and amino acids, among others. Furthermore, metabolic pathway analysis revealed important alterations in homeostasis of lipids, energy management, and metabolism of amino acids and nucleotides. Therefore, these findings demonstrate the potential of metabolomic screening and the use of transgenic models for understanding pathogenesis of Alzheimer's disease. •Direct infusion mass spectrometry allows a comprehensive brain metabolomic analysis.•The APP/PS1 mice exhibited an abnormal neurochemical profile compared to controls.•These failures affected hippocampus, cortex, cerebellum and olfactory bulbs.•Pathway analysis revealed multiple significant impairments in brain metabolism. The identification of pathological mechanisms underlying to Alzheimer's disease is of great importance for the discovery of potential markers for diagnosis and disease monitoring. In this study, we investigated regional metabolic alterations in brain from the APP/PS1 mice, a transgenic model that reproduces well some of the neuropathological and cognitive deficits observed in human Alzheimer's disease. For this purpose, hippocampus, cortex, cerebellum and olfactory bulbs were analyzed using a high-throughput metabolomic approach based on direct infusion mass spectrometry. Metabolic fingerprints showed significant differences between transgenic and wild-type mice in all brain tissues, being hippocampus and cortex the most affected regions. Alterations in numerous metabolites were detected including phospholipids, fatty acids, purine and pyrimidine metabolites, acylcarnitines, sterols and amino acids, among others. Furthermore, metabolic pathway analysis revealed important alterations in homeostasis of lipids, energy management, and metabolism of amino acids and nucleotides. Therefore, these findings demonstrate the potential of metabolomic screening and the use of transgenic models for understanding pathogenesis of Alzheimer's disease. |
Author | Gómez-Ariza, José Luis González-Domínguez, Raúl García-Barrera, Tamara Vitorica, Javier |
Author_xml | – sequence: 1 givenname: Raúl surname: González-Domínguez fullname: González-Domínguez, Raúl organization: Department of Chemistry and CC.MM, Faculty of Experimental Sciences, University of Huelva, Campus de El Carmen, 21007 Huelva, Spain – sequence: 2 givenname: Tamara surname: García-Barrera fullname: García-Barrera, Tamara email: tamara@dqcm.uhu.es organization: Department of Chemistry and CC.MM, Faculty of Experimental Sciences, University of Huelva, Campus de El Carmen, 21007 Huelva, Spain – sequence: 3 givenname: Javier surname: Vitorica fullname: Vitorica, Javier organization: Department Bioquímica, Bromatologia, Toxicología y Medicina Legal, Faculty of Pharmacy, University of Seville, 41012 Seville, Spain – sequence: 4 givenname: José Luis surname: Gómez-Ariza fullname: Gómez-Ariza, José Luis email: ariza@uhu.es organization: Department of Chemistry and CC.MM, Faculty of Experimental Sciences, University of Huelva, Campus de El Carmen, 21007 Huelva, Spain |
BackLink | https://www.ncbi.nlm.nih.gov/pubmed/25459942$$D View this record in MEDLINE/PubMed |
BookMark | eNqNkc1uEzEUhS1URNPCC7BA3sEmqe2x50diE1X8SUVEAiR2lu25Th3NjIOvUym8BK-Mh7QbFhUrXx-d7yzOuSBnU5yAkJecrTjj9dVutdtbsxKMyyKsGOuekAVvm2opavnjjCxYU_Flw1p1Ti4Qd4wxxTv5jJwLJVXXSbEgvz9DNjYOcQyOoksAU5i2NHqaYBviZAZqkwkTNUOGZHKRkJZvvgW63myuNl85zclMuC2go2PsYZjp9fDrFsII6TXSPiAYBGqP5UzgcgnwByxRdDSIFPdFS3GEnI7PyVNvBoQX9-8l-f7-3bfrj8ubLx8-Xa9vlk52XV620ForasWs90apxjIFsmZVI3vT8c743tbCNUKxyjPjufU1yMoIqJh3Tc2rS_LmlLtP8ecBMOsxoINhMBPEA2pel7S2FZz9h1UJWTV12xXrq3vrwY7Q630Ko0lH_dB3MbQng0sRMYHXLuS_rZYSw6A50_O0eqfnafU87ayVaQsq_kEf0h-F3p4gKF3eBUgaXYDJwWkI3cfwGP4HQ7y-sg |
CitedBy_id | crossref_primary_10_1016_j_bbih_2023_100599 crossref_primary_10_1016_j_talanta_2022_124046 crossref_primary_10_1016_j_jprot_2016_07_032 crossref_primary_10_1371_journal_pone_0155694 crossref_primary_10_1021_acs_jproteome_8b00847 crossref_primary_10_1371_journal_pone_0174763 crossref_primary_10_1007_s12035_019_1586_2 crossref_primary_10_1016_j_neuint_2015_11_005 crossref_primary_10_1021_acs_jproteome_0c00255 crossref_primary_10_1038_s41598_020_63483_w crossref_primary_10_1016_j_heliyon_2024_e39104 crossref_primary_10_1111_nyas_13385 crossref_primary_10_1021_acs_analchem_2c00676 crossref_primary_10_1016_j_bbadis_2023_166910 crossref_primary_10_2174_1567205017666201109091759 crossref_primary_10_1186_s13041_020_0565_x crossref_primary_10_1021_acs_jproteome_0c01050 crossref_primary_10_3389_fphar_2021_788312 crossref_primary_10_3390_biomedicines9030298 crossref_primary_10_1016_j_nut_2021_111499 crossref_primary_10_4155_bio_2016_0202 crossref_primary_10_1016_j_bbadis_2017_10_028 crossref_primary_10_1039_C8RA01574K crossref_primary_10_3389_fnut_2021_769218 crossref_primary_10_1016_j_jpba_2015_01_025 crossref_primary_10_3389_fneur_2017_00719 crossref_primary_10_1080_14789450_2021_1948330 crossref_primary_10_1172_jci_insight_150099 crossref_primary_10_3389_fnagi_2022_1023493 crossref_primary_10_1016_j_exger_2016_12_019 crossref_primary_10_1021_acs_analchem_5b02871 crossref_primary_10_1038_s41598_020_71510_z crossref_primary_10_1124_pharmrev_122_000679 crossref_primary_10_1016_j_biochi_2015_01_005 crossref_primary_10_1186_s13195_024_01549_x crossref_primary_10_1002_jnr_24750 crossref_primary_10_1016_j_jchromb_2017_02_008 crossref_primary_10_1016_j_brainres_2021_147481 crossref_primary_10_1038_s41598_023_30892_6 crossref_primary_10_1093_braincomms_fcab139 crossref_primary_10_1016_j_arr_2023_101987 crossref_primary_10_1039_C4MB00747F crossref_primary_10_1016_j_jgr_2015_04_006 crossref_primary_10_1016_j_jchromb_2016_09_023 crossref_primary_10_3390_ijms24054960 crossref_primary_10_1038_s41598_020_68739_z crossref_primary_10_1002_ctd2_287 crossref_primary_10_3390_nu14040735 crossref_primary_10_1038_s41598_020_70703_w crossref_primary_10_1007_s12035_023_03533_2 crossref_primary_10_3233_JAD_170880 crossref_primary_10_3389_fphar_2023_1338804 crossref_primary_10_1016_j_bbrc_2017_09_164 crossref_primary_10_1038_s41598_024_51463_3 crossref_primary_10_1051_ocl_2018027 crossref_primary_10_1016_j_neulet_2020_135401 crossref_primary_10_4155_bio_2018_0135 crossref_primary_10_1007_s41664_017_0018_4 crossref_primary_10_1016_j_plipres_2023_101223 crossref_primary_10_14336_AD_2020_0217 crossref_primary_10_1016_j_jpba_2016_07_008 crossref_primary_10_1186_s13195_023_01162_4 crossref_primary_10_1016_j_pnpbp_2023_110848 crossref_primary_10_3390_ijms231911560 crossref_primary_10_1007_s11306_015_0773_z crossref_primary_10_1002_elps_201400544 crossref_primary_10_3389_fnmol_2021_665788 |
Cites_doi | 10.1016/j.plipres.2011.06.001 10.1371/journal.pone.0032737 10.1016/j.nbd.2012.09.003 10.3233/JAD-2010-100630 10.4061/2011/517160 10.1111/j.1750-3639.2003.tb00475.x 10.1039/b604498k 10.1016/j.bbr.2010.03.026 10.1194/jlr.R300005-JLR200 10.1016/j.brainres.2004.02.079 10.1371/journal.pone.0031501 10.1016/j.molmed.2007.12.001 10.1016/S0197-4580(98)00083-9 10.1007/BF03159937 10.1046/j.1471-4159.1997.68052061.x 10.1074/jbc.M111.274142 10.1186/1471-2164-7-142 10.1007/s12017-012-8173-2 10.1021/pr300666p 10.3233/JAD-130023 10.1007/s11306-012-0449-x 10.3233/JAD-131463 10.1016/j.aca.2004.07.065 10.1016/S0021-9673(02)01838-1 10.1016/0304-3940(95)12256-7 10.1002/jnr.22479 10.1016/j.jprot.2014.01.014 10.1111/j.1750-3639.2007.00112.x 10.2478/s11696-012-0184-9 10.1016/j.bbagen.2010.06.002 10.1093/hmg/ddh019 10.1016/j.brainresbull.2011.11.017 10.1002/mas.20108 10.1007/s11064-008-9673-1 10.1016/j.talanta.2013.09.019 10.1007/BF01705539 10.1046/j.1471-4159.2001.00332.x 10.1002/elps.201100139 10.1007/s11064-004-6871-3 10.1093/bioinformatics/btq418 10.1111/j.1742-4658.2005.04911.x 10.1586/14737159.4.2.189 10.1007/s11306-013-0516-y 10.1016/j.brainres.2009.07.066 10.1016/j.neuint.2010.04.001 10.1194/jlr.D001750 10.1016/j.neurobiolaging.2007.03.002 10.1097/NEN.0b013e31826be03c 10.3390/ijms141021021 10.1016/j.bbr.2012.07.016 10.1016/j.celrep.2012.05.001 10.1007/s00216-013-6825-1 10.1007/s00401-011-0836-9 10.1002/ana.410210403 10.1039/c0an00265h 10.1016/j.ijms.2011.10.002 10.1002/1097-4547(20010301)63:5<395::AID-JNR1034>3.0.CO;2-Q 10.1007/s11306-009-0187-x 10.1007/s11306-013-0610-1 10.1002/nbm.1712 10.1046/j.1471-4159.1998.71052034.x 10.1038/srep02364 10.1016/j.jpba.2014.05.023 10.1002/mas.10061 10.1007/s00726-006-0409-8 10.1016/j.neurobiolaging.2004.02.016 10.2174/1567205011310040005 10.1016/0304-3940(95)12058-C |
ContentType | Journal Article |
Copyright | 2014 Elsevier B.V. Copyright © 2014 Elsevier B.V. All rights reserved. |
Copyright_xml | – notice: 2014 Elsevier B.V. – notice: Copyright © 2014 Elsevier B.V. All rights reserved. |
DBID | AAYXX CITATION CGR CUY CVF ECM EIF NPM 7X8 7QO 7U7 8FD C1K FR3 P64 |
DOI | 10.1016/j.jpba.2014.10.009 |
DatabaseName | CrossRef Medline MEDLINE MEDLINE (Ovid) MEDLINE MEDLINE PubMed MEDLINE - Academic Biotechnology Research Abstracts Toxicology Abstracts Technology Research Database Environmental Sciences and Pollution Management Engineering Research Database Biotechnology and BioEngineering Abstracts |
DatabaseTitle | CrossRef MEDLINE Medline Complete MEDLINE with Full Text PubMed MEDLINE (Ovid) MEDLINE - Academic Engineering Research Database Biotechnology Research Abstracts Technology Research Database Toxicology Abstracts Biotechnology and BioEngineering Abstracts Environmental Sciences and Pollution Management |
DatabaseTitleList | MEDLINE - Academic Engineering Research Database MEDLINE |
Database_xml | – sequence: 1 dbid: NPM name: PubMed url: https://proxy.k.utb.cz/login?url=http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?db=PubMed sourceTypes: Index Database – sequence: 2 dbid: EIF name: MEDLINE url: https://proxy.k.utb.cz/login?url=https://www.webofscience.com/wos/medline/basic-search sourceTypes: Index Database |
DeliveryMethod | fulltext_linktorsrc |
Discipline | Pharmacy, Therapeutics, & Pharmacology |
EISSN | 1873-264X |
EndPage | 435 |
ExternalDocumentID | 25459942 10_1016_j_jpba_2014_10_009 S0731708514005007 |
Genre | Research Support, Non-U.S. Gov't Journal Article |
GroupedDBID | --- --K --M .~1 0R~ 1B1 1RT 1~. 1~5 4.4 457 4G. 5GY 5VS 7-5 71M 8P~ 9JM 9JN AABNK AACTN AAEDT AAEDW AAIAV AAIKJ AAKOC AALRI AAOAW AAQFI AARLI AATCM AAXUO ABFRF ABJNI ABMAC ABYKQ ABZDS ACDAQ ACGFO ACGFS ACIUM ACRLP ADBBV ADECG ADEZE AEBSH AEFWE AEKER AENEX AFKWA AFTJW AFXIZ AFZHZ AGHFR AGUBO AGYEJ AIEXJ AIKHN AITUG AJBFU AJOXV AJSZI ALCLG ALMA_UNASSIGNED_HOLDINGS AMFUW AMRAJ AXJTR BKOJK BLXMC C45 CS3 DU5 EBS EFJIC EFLBG EJD EO8 EO9 EP2 EP3 F5P FDB FIRID FLBIZ FNPLU FYGXN G-Q GBLVA IHE J1W KOM M34 M36 M41 MO0 N9A O-L O9- OAUVE OGGZJ OVD OZT P-8 P-9 P2P PC. Q38 RIG RNS ROL RPZ SCC SCH SDF SDG SDP SES SPC SPCBC SSK SSP SSZ T5K TEORI YK3 ~G- 29L 53G AAQXK AATTM AAXKI AAYWO AAYXX ABFNM ABWVN ABXDB ACNNM ACRPL ACVFH ADCNI ADMUD ADNMO AEIPS AEUPX AFJKZ AFPUW AGCQF AGQPQ AGRNS AHHHB AIGII AIIUN AJQLL AKBMS AKRWK AKYEP ANKPU APXCP ASPBG AVWKF AZFZN BNPGV CITATION FEDTE FGOYB G-2 HMT HMU HVGLF HZ~ R2- SCB SEW SPT SSH WUQ XPP CGR CUY CVF ECM EIF NPM 7X8 EFKBS 7QO 7U7 8FD C1K FR3 P64 |
ID | FETCH-LOGICAL-c499t-8e8bb2650bffa557b05e460374da919afdb62c72503f0af1bf6e43a2e30fc7613 |
IEDL.DBID | .~1 |
ISSN | 0731-7085 1873-264X |
IngestDate | Tue Aug 05 10:35:27 EDT 2025 Sun Aug 24 03:01:39 EDT 2025 Thu Apr 03 07:00:49 EDT 2025 Thu Apr 24 22:52:36 EDT 2025 Tue Jul 01 01:17:37 EDT 2025 Fri Feb 23 02:34:15 EST 2024 |
IsDoiOpenAccess | false |
IsOpenAccess | true |
IsPeerReviewed | true |
IsScholarly | true |
Keywords | Metabolomics Brain regions Direct infusion mass spectrometry APP/PS1 mice Alzheimer's disease |
Language | English |
License | Copyright © 2014 Elsevier B.V. All rights reserved. |
LinkModel | DirectLink |
MergedId | FETCHMERGED-LOGICAL-c499t-8e8bb2650bffa557b05e460374da919afdb62c72503f0af1bf6e43a2e30fc7613 |
Notes | ObjectType-Article-1 SourceType-Scholarly Journals-1 ObjectType-Feature-2 content type line 23 |
OpenAccessLink | http://hdl.handle.net/10272/14594 |
PMID | 25459942 |
PQID | 1652437689 |
PQPubID | 23479 |
PageCount | 11 |
ParticipantIDs | proquest_miscellaneous_1660388210 proquest_miscellaneous_1652437689 pubmed_primary_25459942 crossref_citationtrail_10_1016_j_jpba_2014_10_009 crossref_primary_10_1016_j_jpba_2014_10_009 elsevier_sciencedirect_doi_10_1016_j_jpba_2014_10_009 |
ProviderPackageCode | CITATION AAYXX |
PublicationCentury | 2000 |
PublicationDate | 2015-01-05 |
PublicationDateYYYYMMDD | 2015-01-05 |
PublicationDate_xml | – month: 01 year: 2015 text: 2015-01-05 day: 05 |
PublicationDecade | 2010 |
PublicationPlace | England |
PublicationPlace_xml | – name: England |
PublicationTitle | Journal of pharmaceutical and biomedical analysis |
PublicationTitleAlternate | J Pharm Biomed Anal |
PublicationYear | 2015 |
Publisher | Elsevier B.V |
Publisher_xml | – name: Elsevier B.V |
References | Strott, Higashi (bib0285) 2003; 44 Lo, Callaerts-Vegh, Nunes, Rodrigues, D‘Hooge (bib0295) 2013; 50 Fabelo, Martín, Marín, Santpere, Aso, Ferrer, Díaz (bib0280) 2012; 71 Gonzalez-Dominguez, Garcia-Barrera, Gomez-Ariza (bib0165) 2014; 104 Perry, Yong, Bergeron, Hansen, Jones (bib0330) 1987; 21 Fonteh, Harrington, Tsai, Liao, Harrington (bib0305) 2007; 32 Lokhov, Kharybin, Archakov (bib0155) 2012; 309 Frisardi, Panza, Seripa, Farooqui, Farooqui (bib0185) 2011; 50 Gabbita, Lovell, Markesbery (bib0275) 1998; 71 Pulfer, Murphy (bib0125) 2003; 22 Cai, Yan, Li, Quazi, Zhao (bib0250) 2012; 14 Lokhov, Dashtiev, Moshkovskii, Archakov (bib0150) 2010; 6 Lyras, Cairns, Jenner, Jenner, Halliwell (bib0270) 1997; 68 Albasanz, Perez, Barrachina, Ferrer, Martín (bib0255) 2008; 18 Yang, He, Schulz (bib0230) 2005; 272 Lin, Kanawati, Liu, Witting, Li, Huang, Schmitt-Kopplin, Cai (bib0105) 2014; 118 Woo, Lee, Lee, Kim, Kim, Rhim, Choi, Kim, Lee, Choe (bib0060) 2010; 211 Axelsen, Murphy (bib0210) 2010; 51 Yao, Wengenack, Curran, Poduslo (bib0190) 2009; 34 Hu, Browne, Liu, Angel, Ho, Chan (bib0080) 2012; 11 Lin, Yu, Yan, Hang, Zheng, Xing, Huang (bib0145) 2010; 135 Kou, Kovacs, Höftberger, Kulik, Brodde, Forss-Petter, Hönigschnabl, Gleiss, Brügger, Wanders, Just, Budka, Jungwirth, Fischer, Berger (bib0205) 2011; 122 Xia, Wishart (bib0140) 2010; 26 Yao, Hamilton, Cadenas, Brinton (bib0225) 2010; 1800 Sims, Powers, Sabina, Theibert (bib0245) 1998; 19 Cuadrado-Tejedor, Cabodevilla, Zamarbide, Gómez-Isla, Franco, Perez-Mediavilla (bib0235) 2013; 10 Filalia, Lalonde (bib0015) 2009; 1292 Yatin, Yatin, Varadarajan, Ain, Butterfield (bib0315) 2001; 63 Angulo, Casadó, Mallol, Canela, Viñals, Ferrer, Lluis, Franco (bib0260) 2003; 13 Vernez, Hopfgartner, Wenk, Krahenbuhl (bib0135) 2003; 984 Salek, Xia, Innes, Sweatman, Adalbert, Randle, McGowan, Emson, Griffin (bib0055) 2010; 56 Trushina, Nemutlu, Zhang, Christensen, Camp, Mesa, Siddiqui, Tamura, Sesaki, Wengenack, Dzeja, Poduslo (bib0085) 2012; 7 Ramalho, Viana, Low, Steer, Rodrigues (bib0290) 2008; 14 Walter, Korth, Hilgert, Hartmann, Weichel, Hilgert, Fassbender, Schmitt, Klein (bib0180) 2004; 25 van den Berg, Hoefsloot, Westerhuis, Smilde, van der Werf (bib0120) 2006; 7 Draper, Lloyd, Goodacre, Beckmann (bib0095) 2013; 9 Hansmannel, Sillaire, Kamboh, Lendon, Pasquier, Hannequin, Laumet, Mounier, Ayral, DeKosky, Hauw, Berr, Mann, Amouyel, Campion, Lambert (bib0325) 2010; 21 Wang, Xie, Yang, Yang, Xu (bib0130) 2004; 525 Lindon, Holmes, Nicholson (bib0020) 2004; 4 Chan, Oliveira, Cortes, Honig, Duff, Small, Wenk, Shui, Di Paolo (bib0200) 2012; 287 Malm, Koistinaho, Kanninen (bib0010) 2011; 2011 Samakashvili, Ibáñez, Simó, Gil-Bea, Winblad, Cedazo-Mínguez, Cifuentes (bib0310) 2011; 32 Makar, Cooper, Tofel-Grehl, Thaler, Blass (bib0220) 1995; 20 Storga, Vrecko, Birkmayer, Reibnegger (bib0300) 1996; 203 Graham, Holscher, McClean, Elliott, Green (bib0050) 2013; 9 Jankowsky, Fadale, Anderson, Xu, Gonzales, Jenkins, Copeland, Lee, Younkin, Wagner, Younkin, Borchelt (bib0110) 2004; 13 González-Domínguez, García-Barrera, Gómez-Ariza (bib0170) 2014; 98 Oberg, Spenger, Wang, Andersson, Westman, Skoglund, Sunnemark, Norinder, Klason, Wahlund, Lindberg (bib0025) 2008; 29 Dettmer, Aronov, Hammock (bib0070) 2007; 26 Piro, Benjamin, Duerr, Pi, Gonzales, Wood, Schwartz, Nomura, Samad (bib0075) 2012; 1 Gonzalez-Dominguez, Garcia-Barrera, Gomez-Ariza (bib0160) 2012; 66 Forster, James, Williams (bib0045) 2012; 25 Adams, Klaidman, Odunze, Shen, Miller (bib0340) 1991; 14 Sangster, Major, Plumb, Wilson, Wilson (bib0115) 2006; 131 Han, Holtzman (bib0195) 2001; 77 Chen, Cai, Shen, Wang, Teng, Zhang, Zang (bib0035) 2012; 235 Wang, Lian, Han, Wang, Kuo, Geng, Qiang, Sun, Wang (bib0090) 2014; 39 Xu, Zhan, Huang, Wang, Zhang, Lei (bib0030) 2010; 88 Hall, Roberson (bib0005) 2012; 88 Graham, Holscher, Green (bib0215) 2014; 10 Aoyama, Nakaki (bib0335) 2013; 14 Lalande, Halley, Balayssac, Gilard, Déjean, Martino, Francés, Lassalle, Malet-Martino (bib0065) 2014; 39 Czech, Berndt, Busch, Schmitz, Wiemer, Most, Hampel, Kastler, Senn (bib0265) 2012; 7 Lin, Liu, Kanawati, Liu, Dong, Li, Huang, Schmitt-Kopplin, Cai (bib0100) 2013; 405 Parnetti, Gaiti, Polidori, Brunetti, Palumbo, Chionne, Cadini, Cecchetti, Senin (bib0345) 2005; 199 Dedeoglu, Choi, Cormier, Kowall, Jenkins (bib0040) 2004; 1012 Farooqui, Ong, Horrocks (bib0175) 2004; 29 Inoue, Tsutsui, Akatsu, Hashizume, Matsukawa, Yamamoto, Toyo’oka (bib0320) 2013; 3 Fabelo (10.1016/j.jpba.2014.10.009_bib0280) 2012; 71 Wang (10.1016/j.jpba.2014.10.009_bib0090) 2014; 39 Lin (10.1016/j.jpba.2014.10.009_bib0145) 2010; 135 Makar (10.1016/j.jpba.2014.10.009_bib0220) 1995; 20 Sangster (10.1016/j.jpba.2014.10.009_bib0115) 2006; 131 Ramalho (10.1016/j.jpba.2014.10.009_bib0290) 2008; 14 Lin (10.1016/j.jpba.2014.10.009_bib0105) 2014; 118 Gonzalez-Dominguez (10.1016/j.jpba.2014.10.009_bib0165) 2014; 104 Xia (10.1016/j.jpba.2014.10.009_bib0140) 2010; 26 Lo (10.1016/j.jpba.2014.10.009_bib0295) 2013; 50 Forster (10.1016/j.jpba.2014.10.009_bib0045) 2012; 25 Yao (10.1016/j.jpba.2014.10.009_bib0225) 2010; 1800 Lokhov (10.1016/j.jpba.2014.10.009_bib0155) 2012; 309 Gonzalez-Dominguez (10.1016/j.jpba.2014.10.009_bib0160) 2012; 66 Kou (10.1016/j.jpba.2014.10.009_bib0205) 2011; 122 Malm (10.1016/j.jpba.2014.10.009_bib0010) 2011; 2011 Sims (10.1016/j.jpba.2014.10.009_bib0245) 1998; 19 Han (10.1016/j.jpba.2014.10.009_bib0195) 2001; 77 Salek (10.1016/j.jpba.2014.10.009_bib0055) 2010; 56 Parnetti (10.1016/j.jpba.2014.10.009_bib0345) 2005; 199 Aoyama (10.1016/j.jpba.2014.10.009_bib0335) 2013; 14 Trushina (10.1016/j.jpba.2014.10.009_bib0085) 2012; 7 Filalia (10.1016/j.jpba.2014.10.009_bib0015) 2009; 1292 González-Domínguez (10.1016/j.jpba.2014.10.009_bib0170) 2014; 98 Chen (10.1016/j.jpba.2014.10.009_bib0035) 2012; 235 Wang (10.1016/j.jpba.2014.10.009_bib0130) 2004; 525 Gabbita (10.1016/j.jpba.2014.10.009_bib0275) 1998; 71 Hu (10.1016/j.jpba.2014.10.009_bib0080) 2012; 11 Angulo (10.1016/j.jpba.2014.10.009_bib0260) 2003; 13 Perry (10.1016/j.jpba.2014.10.009_bib0330) 1987; 21 Xu (10.1016/j.jpba.2014.10.009_bib0030) 2010; 88 Inoue (10.1016/j.jpba.2014.10.009_bib0320) 2013; 3 Woo (10.1016/j.jpba.2014.10.009_bib0060) 2010; 211 Albasanz (10.1016/j.jpba.2014.10.009_bib0255) 2008; 18 Lin (10.1016/j.jpba.2014.10.009_bib0100) 2013; 405 Cai (10.1016/j.jpba.2014.10.009_bib0250) 2012; 14 Hall (10.1016/j.jpba.2014.10.009_bib0005) 2012; 88 Oberg (10.1016/j.jpba.2014.10.009_bib0025) 2008; 29 Chan (10.1016/j.jpba.2014.10.009_bib0200) 2012; 287 Fonteh (10.1016/j.jpba.2014.10.009_bib0305) 2007; 32 Yatin (10.1016/j.jpba.2014.10.009_bib0315) 2001; 63 Walter (10.1016/j.jpba.2014.10.009_bib0180) 2004; 25 Lyras (10.1016/j.jpba.2014.10.009_bib0270) 1997; 68 Dedeoglu (10.1016/j.jpba.2014.10.009_bib0040) 2004; 1012 Hansmannel (10.1016/j.jpba.2014.10.009_bib0325) 2010; 21 van den Berg (10.1016/j.jpba.2014.10.009_bib0120) 2006; 7 Draper (10.1016/j.jpba.2014.10.009_bib0095) 2013; 9 Yao (10.1016/j.jpba.2014.10.009_bib0190) 2009; 34 Graham (10.1016/j.jpba.2014.10.009_bib0050) 2013; 9 Cuadrado-Tejedor (10.1016/j.jpba.2014.10.009_bib0235) 2013; 10 Adams (10.1016/j.jpba.2014.10.009_bib0340) 1991; 14 Lalande (10.1016/j.jpba.2014.10.009_bib0065) 2014; 39 Frisardi (10.1016/j.jpba.2014.10.009_bib0185) 2011; 50 Samakashvili (10.1016/j.jpba.2014.10.009_bib0310) 2011; 32 Axelsen (10.1016/j.jpba.2014.10.009_bib0210) 2010; 51 Graham (10.1016/j.jpba.2014.10.009_bib0215) 2014; 10 Piro (10.1016/j.jpba.2014.10.009_bib0075) 2012; 1 Czech (10.1016/j.jpba.2014.10.009_bib0265) 2012; 7 Vernez (10.1016/j.jpba.2014.10.009_bib0135) 2003; 984 Storga (10.1016/j.jpba.2014.10.009_bib0300) 1996; 203 Jankowsky (10.1016/j.jpba.2014.10.009_bib0110) 2004; 13 Yang (10.1016/j.jpba.2014.10.009_bib0230) 2005; 272 Strott (10.1016/j.jpba.2014.10.009_bib0285) 2003; 44 Lokhov (10.1016/j.jpba.2014.10.009_bib0150) 2010; 6 Dettmer (10.1016/j.jpba.2014.10.009_bib0070) 2007; 26 Pulfer (10.1016/j.jpba.2014.10.009_bib0125) 2003; 22 Lindon (10.1016/j.jpba.2014.10.009_bib0020) 2004; 4 Farooqui (10.1016/j.jpba.2014.10.009_bib0175) 2004; 29 |
References_xml | – volume: 11 start-page: 5903 year: 2012 end-page: 5913 ident: bib0080 article-title: Metabonomic profiling of TASTPM transgenic alzheimer's disease mouse model publication-title: J. Proteome Res. – volume: 13 start-page: 159 year: 2004 end-page: 170 ident: bib0110 article-title: Mutant presenilins specifically elevate the levels of the 42 residue beta-amyloid peptide in vivo: evidence for augmentation of a 42-specific g secretase publication-title: Hum. Mol. Genet. – volume: 1800 start-page: 1121 year: 2010 end-page: 1126 ident: bib0225 article-title: Decline in mitochondrial bioenergetics and shift to ketogenic profile in brain during reproductive senescence publication-title: Biochim. Biophys. Acta – volume: 32 start-page: 213 year: 2007 end-page: 224 ident: bib0305 article-title: Free amino acid and dipeptide changes in the body fluids from Alzheimer's disease subjects publication-title: Amino Acids – volume: 1012 start-page: 60 year: 2004 end-page: 65 ident: bib0040 article-title: Magnetic resonance spectroscopic analysis of Alzheimer's disease mouse brain that express mutant human APP shows altered neurochemical profile publication-title: Brain Res. – volume: 39 start-page: 121 year: 2014 end-page: 143 ident: bib0065 article-title: H NMR metabolomic signatures in five brain regions of the AβPPswe Tg2576 mouse model of Alzheimer's disease at four ages publication-title: J. Alzheimers Dis. – volume: 211 start-page: 125 year: 2010 end-page: 131 ident: bib0060 article-title: Regional metabolic alteration of Alzheimer's disease in mouse brain expressing mutant human APP–PS1 by publication-title: Behav. Brain Res. – volume: 287 start-page: 2678 year: 2012 end-page: 2688 ident: bib0200 article-title: Comparative lipidomic analysis of mouse and human brain with Alzheimer disease publication-title: J. Biol. Chem. – volume: 6 start-page: 156 year: 2010 end-page: 163 ident: bib0150 article-title: Metabolite profiling of blood plasma of patients with prostate cancer publication-title: Metabolomics – volume: 18 start-page: 211 year: 2008 end-page: 219 ident: bib0255 article-title: Up-regulation of adenosine receptors in the frontal cortex in Alzheimer's disease publication-title: Brain Pathol. – volume: 13 start-page: 440 year: 2003 end-page: 451 ident: bib0260 article-title: A1 adenosine receptors accumulate in neurodegenerative structures in Alzheimer's disease and mediate both amyloid precursor protein processing and tau phosphorylation and translocation publication-title: Brain Pathol. – volume: 2011 start-page: 517160 year: 2011 ident: bib0010 article-title: Utilization of APPswe/PS1dE9 transgenic mice in research of Alzheimer's disease: focus on gene therapy and cell-based therapy applications publication-title: Int. J. Alzheimers Dis. – volume: 118 start-page: 45 year: 2014 end-page: 53 ident: bib0105 article-title: Ultra high resolution mass spectrometry-based metabolic characterization reveals cerebellum as a disturbed region in two animal models publication-title: Talanta – volume: 26 start-page: 51 year: 2007 end-page: 78 ident: bib0070 article-title: Mass spectrometry-based metabolomics publication-title: Mass Spectrom. Rev. – volume: 25 start-page: 1299 year: 2004 end-page: 1303 ident: bib0180 article-title: Glycerophosphocholine is elevated in cerebrospinal fluid of Alzheimer patients publication-title: Neurobiol. Aging – volume: 272 start-page: 4874 year: 2005 end-page: 4883 ident: bib0230 article-title: 3-Hydroxyacyl-CoA dehydrogenase and short chain 3-hydroxyacyl-CoA dehydrogenase in human health and disease publication-title: FEBS J. – volume: 26 start-page: 2342 year: 2010 end-page: 2344 ident: bib0140 article-title: MetPA: a web-based metabolomics tool for pathway analysis and visualization publication-title: Bioinformatics – volume: 77 start-page: 1168 year: 2001 end-page: 1180 ident: bib0195 article-title: McKeel Jr DW. Plasmalogen deficiency in early Alzheimer's disease subjects and in animal models: molecular characterization using electrospray ionization mass spectrometry publication-title: J. Neurochem. – volume: 984 start-page: 203 year: 2003 end-page: 213 ident: bib0135 article-title: Determination of carnitine and acylcarnitines in urine by high-performance liquid chromatography–electrospray ionization ion trap tandem mass spectrometry publication-title: J. Chromatogr. A – volume: 405 start-page: 5105 year: 2013 end-page: 5117 ident: bib0100 article-title: Hippocampal metabolomics using ultrahigh-resolution mass spectrometry reveals neuroinflammation from Alzheimer's disease in CRND8 mice publication-title: Anal. Bioanal. Chem. – volume: 309 start-page: 200 year: 2012 end-page: 205 ident: bib0155 article-title: Diagnosis of lung cancer based on direct-infusion electrospray mass spectrometry of blood plasma metabolites publication-title: Int. J. Mass Spectrom. – volume: 34 start-page: 102 year: 2009 end-page: 108 ident: bib0190 article-title: Reduced membrane lipids in the cortex of Alzheimer's disease transgenic mice publication-title: Neurochem. Res. – volume: 21 start-page: 1013 year: 2010 end-page: 1021 ident: bib0325 article-title: Is the urea cycle involved in Alzheimer's disease publication-title: J. Alzheimers Dis. – volume: 56 start-page: 937 year: 2010 end-page: 943 ident: bib0055 article-title: A metabolomic study of the CRND8 transgenic mouse model of Alzheimer's disease publication-title: Neurochem. Int. – volume: 3 start-page: 2364 year: 2013 ident: bib0320 article-title: Metabolic profiling of Alzheimer's disease brains publication-title: Sci. Rep. – volume: 39 start-page: 841 year: 2014 end-page: 848 ident: bib0090 article-title: Age-related alterations in the metabolic profile in the hippocampus of the senescence-accelerated mouse prone 8: a spontaneous Alzheimer's disease mouse model publication-title: J. Alzheimers Dis. – volume: 1 start-page: 617 year: 2012 end-page: 623 ident: bib0075 article-title: A dysregulated endocannabinoid-eicosanoid network supports pathogenesis in a mouse model of Alzheimer's disease publication-title: Cell Rep. – volume: 7 start-page: 142 year: 2006 ident: bib0120 article-title: Centering, scaling, and transformations: improving the biological information content of metabolomics data publication-title: BMC Genomics – volume: 20 start-page: 705 year: 1995 end-page: 711 ident: bib0220 article-title: Carnitine, carnitine acetyltransferase, and glutathione in Alzheimer brain publication-title: Neurochem. Res. – volume: 135 start-page: 2970 year: 2010 end-page: 2978 ident: bib0145 article-title: Direct infusion mass spectrometry or liquid chromatography mass spectrometry for human metabonomics? A serum metabonomic study of kidney cancer publication-title: Analyst – volume: 14 start-page: 21021 year: 2013 end-page: 21044 ident: bib0335 article-title: Impaired glutathione synthesis in neurodegeneration publication-title: Int. J. Mol. Sci. – volume: 235 start-page: 1 year: 2012 end-page: 6 ident: bib0035 article-title: Age-related changes in brain metabolites and cognitive function in APP/PS1 transgenic mice publication-title: Behav. Brain Res. – volume: 14 start-page: 54 year: 2008 end-page: 62 ident: bib0290 article-title: Bile acids and apoptosis modulation: an emerging role in experimental Alzheimer's disease publication-title: Trends Mol. Med. – volume: 50 start-page: 313 year: 2011 end-page: 330 ident: bib0185 article-title: Glycerophospholipids and glycerophospholipid-derived lipid mediators: a complex meshwork in Alzheimer's disease pathology publication-title: Prog. Lipid Res. – volume: 21 start-page: 331 year: 1987 end-page: 336 ident: bib0330 article-title: Amino acids, glutathione, and glutathione transferase activity in the brains of patients with Alzheimer's disease publication-title: Ann. Neurol. – volume: 4 start-page: 189 year: 2004 end-page: 199 ident: bib0020 article-title: Metabonomics and its role in drug development and disease diagnosis publication-title: Expert Rev. Mol. Diagn. – volume: 29 start-page: 1961 year: 2004 end-page: 1977 ident: bib0175 article-title: Biochemical aspects of neurodegeneration in human brain: involvement of neural membrane phospholipids and phospholipases A publication-title: Neurochem. Res. – volume: 88 start-page: 3 year: 2012 end-page: 12 ident: bib0005 article-title: Mouse models of Alzheimer's disease publication-title: Brain Res. Bull. – volume: 88 start-page: 3155 year: 2010 end-page: 3160 ident: bib0030 article-title: Reduction of hippocampal N-acetyl aspartate level in aged APPSwe/PS1dE9 transgenic mice is associated with degeneration of CA3 pyramidal neurons publication-title: J. Neurosci. Res. – volume: 50 start-page: 21 year: 2013 end-page: 29 ident: bib0295 article-title: Tauroursodeoxycholic acid (TUDCA) supplementation prevents cognitive impairment and amyloid deposition in APP/PS1 mice publication-title: Neurobiol. Dis. – volume: 122 start-page: 271 year: 2011 end-page: 283 ident: bib0205 article-title: Peroxisomal alterations in Alzheimer's disease publication-title: Acta Neuropathol. – volume: 19 start-page: 385 year: 1998 end-page: 391 ident: bib0245 article-title: Elevated adenosine monophosphate deaminase activity in Alzheimer's disease brain publication-title: Neurobiol. Aging – volume: 22 start-page: 332 year: 2003 end-page: 364 ident: bib0125 article-title: Electrospray mass spectrometry of phospholipids publication-title: Mass Spectrom. Rev. – volume: 63 start-page: 395 year: 2001 end-page: 401 ident: bib0315 article-title: Role of spermine in amyloid β-peptide-associated free radical-induced neurotoxicity publication-title: J. Neurosci. Res. – volume: 104 start-page: 37 year: 2014 end-page: 47 ident: bib0165 article-title: Combination of metabolomic and phospholipid-profiling approaches for the study of Alzheimer's disease publication-title: J. Proteomics – volume: 44 start-page: 1268 year: 2003 end-page: 1278 ident: bib0285 article-title: Cholesterol sulfate in human physiology: what's it all about publication-title: J. Lipid Res. – volume: 29 start-page: 1423 year: 2008 end-page: 1433 ident: bib0025 article-title: Age related changes in brain metabolites observed by publication-title: Neurobiol. Aging – volume: 25 start-page: 52 year: 2012 end-page: 58 ident: bib0045 article-title: Effects of Alzheimer's disease transgenes on neurochemical expression in the mouse brain determined by publication-title: NMR Biomed. – volume: 10 start-page: 390 year: 2013 end-page: 405 ident: bib0235 article-title: Age-related mitochondrial alterations without neuronal loss in the hippocampus of a transgenic model of Alzheimer's disease publication-title: Curr. Alzheimer Res. – volume: 7 start-page: e32737 year: 2012 ident: bib0085 article-title: Defects in mitochondrial dynamics and metabolomic signatures of evolving energetic stress in mouse models of familial Alzheimer's disease publication-title: PLoS ONE – volume: 10 start-page: 744 year: 2014 end-page: 753 ident: bib0215 article-title: Metabolic signatures of human Alzheimer's disease (AD): publication-title: Metabolomics – volume: 7 start-page: e31501 year: 2012 ident: bib0265 article-title: Metabolite profiling of Alzheimer's disease cerebrospinal fluid publication-title: PLoS ONE – volume: 525 start-page: 1 year: 2004 end-page: 10 ident: bib0130 article-title: Structural identification of human blood phospholipids using liquid chromatography/quadrupole-linear ion trap mass spectrometry publication-title: Anal. Chim. Acta – volume: 71 start-page: 2034 year: 1998 end-page: 2040 ident: bib0275 article-title: Increased nuclear DNA oxidation in the brain in Alzheimer's disease publication-title: J. Neurochem. – volume: 9 start-page: 974 year: 2013 end-page: 983 ident: bib0050 article-title: H NMR metabolomics investigation of an Alzheimer's disease (AD) mouse model pinpoints important biochemical disturbances in brain and plasma publication-title: Metabolomics – volume: 131 start-page: 1075 year: 2006 end-page: 1078 ident: bib0115 article-title: A pragmatic and readily implemented quality control strategy for HPLC-MS and GC-MS-based metabonomic analysis publication-title: Analyst – volume: 9 start-page: S4 year: 2013 end-page: S29 ident: bib0095 article-title: Flow infusion electrospray ionisation mass spectrometry for high throughput, non-targeted metabolite fingerprinting: a review publication-title: Metabolomics – volume: 14 start-page: 213 year: 1991 end-page: 226 ident: bib0340 article-title: Alzheimer's and Parkinson's disease. Brain levels of glutathione, glutathione disulfide, and vitamin E publication-title: Mol. Chem. Neuropathol. – volume: 32 start-page: 2757 year: 2011 end-page: 2764 ident: bib0310 article-title: Analysis of chiral amino acids in cerebrospinal fluid samples linked to different stages of Alzheimer disease publication-title: Electrophoresis – volume: 66 start-page: 829 year: 2012 end-page: 835 ident: bib0160 article-title: Metabolomic approach to Alzheimer's disease diagnosis based on mass spectrometry publication-title: Chem. Papers – volume: 71 start-page: 868 year: 2012 end-page: 881 ident: bib0280 article-title: Evidence for premature lipid raft aging in APP/PS1 double-transgenic mice, a model of familial Alzheimer disease publication-title: J. Neuropathol. Exp. Neurol. – volume: 203 start-page: 29 year: 1996 end-page: 32 ident: bib0300 article-title: Monoaminergic neurotransmitters, their precursors and metabolites in brains of Alzheimer patients publication-title: Neurosci. Lett. – volume: 68 start-page: 2061 year: 1997 end-page: 2069 ident: bib0270 article-title: An assessment of oxidative damage to proteins, lipids, and DNA in brain from patients with Alzheimer's disease publication-title: J. Neurochem. – volume: 98 start-page: 321 year: 2014 end-page: 326 ident: bib0170 article-title: Metabolomic study of lipids in serum for biomarker discovery in Alzheimer's disease using direct infusion mass spectrometry publication-title: J. Pharm. Biomed. Anal. – volume: 199 start-page: 231 year: 2005 end-page: 233 ident: bib0345 article-title: Increased cerebrospinal fluid pyruvate levels in Alzheimer's disease publication-title: Neurosci. Lett. – volume: 51 start-page: 660 year: 2010 end-page: 671 ident: bib0210 article-title: Quantitative analysis of phospholipids containing arachidonate and docosahexaenoate chains in microdissected regions of mouse brain publication-title: J. Lipid Res. – volume: 1292 start-page: 93 year: 2009 end-page: 99 ident: bib0015 article-title: Age-related cognitive decline and nesting behavior in an APPswe/PS1 bigenic model of Alzheimer's disease publication-title: Brain Res. – volume: 14 start-page: 1 year: 2012 end-page: 14 ident: bib0250 article-title: Roles of AMP-activated protein kinase in Alzheimer's disease publication-title: Neuromol. Med. – volume: 50 start-page: 313 year: 2011 ident: 10.1016/j.jpba.2014.10.009_bib0185 article-title: Glycerophospholipids and glycerophospholipid-derived lipid mediators: a complex meshwork in Alzheimer's disease pathology publication-title: Prog. Lipid Res. doi: 10.1016/j.plipres.2011.06.001 – volume: 7 start-page: e32737 year: 2012 ident: 10.1016/j.jpba.2014.10.009_bib0085 article-title: Defects in mitochondrial dynamics and metabolomic signatures of evolving energetic stress in mouse models of familial Alzheimer's disease publication-title: PLoS ONE doi: 10.1371/journal.pone.0032737 – volume: 50 start-page: 21 year: 2013 ident: 10.1016/j.jpba.2014.10.009_bib0295 article-title: Tauroursodeoxycholic acid (TUDCA) supplementation prevents cognitive impairment and amyloid deposition in APP/PS1 mice publication-title: Neurobiol. Dis. doi: 10.1016/j.nbd.2012.09.003 – volume: 21 start-page: 1013 year: 2010 ident: 10.1016/j.jpba.2014.10.009_bib0325 article-title: Is the urea cycle involved in Alzheimer's disease publication-title: J. Alzheimers Dis. doi: 10.3233/JAD-2010-100630 – volume: 2011 start-page: 517160 year: 2011 ident: 10.1016/j.jpba.2014.10.009_bib0010 article-title: Utilization of APPswe/PS1dE9 transgenic mice in research of Alzheimer's disease: focus on gene therapy and cell-based therapy applications publication-title: Int. J. Alzheimers Dis. doi: 10.4061/2011/517160 – volume: 13 start-page: 440 year: 2003 ident: 10.1016/j.jpba.2014.10.009_bib0260 article-title: A1 adenosine receptors accumulate in neurodegenerative structures in Alzheimer's disease and mediate both amyloid precursor protein processing and tau phosphorylation and translocation publication-title: Brain Pathol. doi: 10.1111/j.1750-3639.2003.tb00475.x – volume: 131 start-page: 1075 year: 2006 ident: 10.1016/j.jpba.2014.10.009_bib0115 article-title: A pragmatic and readily implemented quality control strategy for HPLC-MS and GC-MS-based metabonomic analysis publication-title: Analyst doi: 10.1039/b604498k – volume: 211 start-page: 125 year: 2010 ident: 10.1016/j.jpba.2014.10.009_bib0060 article-title: Regional metabolic alteration of Alzheimer's disease in mouse brain expressing mutant human APP–PS1 by 1H HR-MAS publication-title: Behav. Brain Res. doi: 10.1016/j.bbr.2010.03.026 – volume: 44 start-page: 1268 year: 2003 ident: 10.1016/j.jpba.2014.10.009_bib0285 article-title: Cholesterol sulfate in human physiology: what's it all about publication-title: J. Lipid Res. doi: 10.1194/jlr.R300005-JLR200 – volume: 1012 start-page: 60 year: 2004 ident: 10.1016/j.jpba.2014.10.009_bib0040 article-title: Magnetic resonance spectroscopic analysis of Alzheimer's disease mouse brain that express mutant human APP shows altered neurochemical profile publication-title: Brain Res. doi: 10.1016/j.brainres.2004.02.079 – volume: 7 start-page: e31501 year: 2012 ident: 10.1016/j.jpba.2014.10.009_bib0265 article-title: Metabolite profiling of Alzheimer's disease cerebrospinal fluid publication-title: PLoS ONE doi: 10.1371/journal.pone.0031501 – volume: 14 start-page: 54 year: 2008 ident: 10.1016/j.jpba.2014.10.009_bib0290 article-title: Bile acids and apoptosis modulation: an emerging role in experimental Alzheimer's disease publication-title: Trends Mol. Med. doi: 10.1016/j.molmed.2007.12.001 – volume: 19 start-page: 385 year: 1998 ident: 10.1016/j.jpba.2014.10.009_bib0245 article-title: Elevated adenosine monophosphate deaminase activity in Alzheimer's disease brain publication-title: Neurobiol. Aging doi: 10.1016/S0197-4580(98)00083-9 – volume: 14 start-page: 213 year: 1991 ident: 10.1016/j.jpba.2014.10.009_bib0340 article-title: Alzheimer's and Parkinson's disease. Brain levels of glutathione, glutathione disulfide, and vitamin E publication-title: Mol. Chem. Neuropathol. doi: 10.1007/BF03159937 – volume: 68 start-page: 2061 year: 1997 ident: 10.1016/j.jpba.2014.10.009_bib0270 article-title: An assessment of oxidative damage to proteins, lipids, and DNA in brain from patients with Alzheimer's disease publication-title: J. Neurochem. doi: 10.1046/j.1471-4159.1997.68052061.x – volume: 287 start-page: 2678 year: 2012 ident: 10.1016/j.jpba.2014.10.009_bib0200 article-title: Comparative lipidomic analysis of mouse and human brain with Alzheimer disease publication-title: J. Biol. Chem. doi: 10.1074/jbc.M111.274142 – volume: 7 start-page: 142 year: 2006 ident: 10.1016/j.jpba.2014.10.009_bib0120 article-title: Centering, scaling, and transformations: improving the biological information content of metabolomics data publication-title: BMC Genomics doi: 10.1186/1471-2164-7-142 – volume: 14 start-page: 1 year: 2012 ident: 10.1016/j.jpba.2014.10.009_bib0250 article-title: Roles of AMP-activated protein kinase in Alzheimer's disease publication-title: Neuromol. Med. doi: 10.1007/s12017-012-8173-2 – volume: 11 start-page: 5903 year: 2012 ident: 10.1016/j.jpba.2014.10.009_bib0080 article-title: Metabonomic profiling of TASTPM transgenic alzheimer's disease mouse model publication-title: J. Proteome Res. doi: 10.1021/pr300666p – volume: 39 start-page: 121 year: 2014 ident: 10.1016/j.jpba.2014.10.009_bib0065 article-title: 1H NMR metabolomic signatures in five brain regions of the AβPPswe Tg2576 mouse model of Alzheimer's disease at four ages publication-title: J. Alzheimers Dis. doi: 10.3233/JAD-130023 – volume: 9 start-page: S4 year: 2013 ident: 10.1016/j.jpba.2014.10.009_bib0095 article-title: Flow infusion electrospray ionisation mass spectrometry for high throughput, non-targeted metabolite fingerprinting: a review publication-title: Metabolomics doi: 10.1007/s11306-012-0449-x – volume: 39 start-page: 841 year: 2014 ident: 10.1016/j.jpba.2014.10.009_bib0090 article-title: Age-related alterations in the metabolic profile in the hippocampus of the senescence-accelerated mouse prone 8: a spontaneous Alzheimer's disease mouse model publication-title: J. Alzheimers Dis. doi: 10.3233/JAD-131463 – volume: 525 start-page: 1 year: 2004 ident: 10.1016/j.jpba.2014.10.009_bib0130 article-title: Structural identification of human blood phospholipids using liquid chromatography/quadrupole-linear ion trap mass spectrometry publication-title: Anal. Chim. Acta doi: 10.1016/j.aca.2004.07.065 – volume: 984 start-page: 203 year: 2003 ident: 10.1016/j.jpba.2014.10.009_bib0135 article-title: Determination of carnitine and acylcarnitines in urine by high-performance liquid chromatography–electrospray ionization ion trap tandem mass spectrometry publication-title: J. Chromatogr. A doi: 10.1016/S0021-9673(02)01838-1 – volume: 203 start-page: 29 year: 1996 ident: 10.1016/j.jpba.2014.10.009_bib0300 article-title: Monoaminergic neurotransmitters, their precursors and metabolites in brains of Alzheimer patients publication-title: Neurosci. Lett. doi: 10.1016/0304-3940(95)12256-7 – volume: 88 start-page: 3155 year: 2010 ident: 10.1016/j.jpba.2014.10.009_bib0030 article-title: Reduction of hippocampal N-acetyl aspartate level in aged APPSwe/PS1dE9 transgenic mice is associated with degeneration of CA3 pyramidal neurons publication-title: J. Neurosci. Res. doi: 10.1002/jnr.22479 – volume: 104 start-page: 37 year: 2014 ident: 10.1016/j.jpba.2014.10.009_bib0165 article-title: Combination of metabolomic and phospholipid-profiling approaches for the study of Alzheimer's disease publication-title: J. Proteomics doi: 10.1016/j.jprot.2014.01.014 – volume: 18 start-page: 211 year: 2008 ident: 10.1016/j.jpba.2014.10.009_bib0255 article-title: Up-regulation of adenosine receptors in the frontal cortex in Alzheimer's disease publication-title: Brain Pathol. doi: 10.1111/j.1750-3639.2007.00112.x – volume: 66 start-page: 829 year: 2012 ident: 10.1016/j.jpba.2014.10.009_bib0160 article-title: Metabolomic approach to Alzheimer's disease diagnosis based on mass spectrometry publication-title: Chem. Papers doi: 10.2478/s11696-012-0184-9 – volume: 1800 start-page: 1121 year: 2010 ident: 10.1016/j.jpba.2014.10.009_bib0225 article-title: Decline in mitochondrial bioenergetics and shift to ketogenic profile in brain during reproductive senescence publication-title: Biochim. Biophys. Acta doi: 10.1016/j.bbagen.2010.06.002 – volume: 13 start-page: 159 year: 2004 ident: 10.1016/j.jpba.2014.10.009_bib0110 article-title: Mutant presenilins specifically elevate the levels of the 42 residue beta-amyloid peptide in vivo: evidence for augmentation of a 42-specific g secretase publication-title: Hum. Mol. Genet. doi: 10.1093/hmg/ddh019 – volume: 88 start-page: 3 year: 2012 ident: 10.1016/j.jpba.2014.10.009_bib0005 article-title: Mouse models of Alzheimer's disease publication-title: Brain Res. Bull. doi: 10.1016/j.brainresbull.2011.11.017 – volume: 26 start-page: 51 year: 2007 ident: 10.1016/j.jpba.2014.10.009_bib0070 article-title: Mass spectrometry-based metabolomics publication-title: Mass Spectrom. Rev. doi: 10.1002/mas.20108 – volume: 34 start-page: 102 year: 2009 ident: 10.1016/j.jpba.2014.10.009_bib0190 article-title: Reduced membrane lipids in the cortex of Alzheimer's disease transgenic mice publication-title: Neurochem. Res. doi: 10.1007/s11064-008-9673-1 – volume: 118 start-page: 45 year: 2014 ident: 10.1016/j.jpba.2014.10.009_bib0105 article-title: Ultra high resolution mass spectrometry-based metabolic characterization reveals cerebellum as a disturbed region in two animal models publication-title: Talanta doi: 10.1016/j.talanta.2013.09.019 – volume: 20 start-page: 705 year: 1995 ident: 10.1016/j.jpba.2014.10.009_bib0220 article-title: Carnitine, carnitine acetyltransferase, and glutathione in Alzheimer brain publication-title: Neurochem. Res. doi: 10.1007/BF01705539 – volume: 77 start-page: 1168 year: 2001 ident: 10.1016/j.jpba.2014.10.009_bib0195 article-title: McKeel Jr DW. Plasmalogen deficiency in early Alzheimer's disease subjects and in animal models: molecular characterization using electrospray ionization mass spectrometry publication-title: J. Neurochem. doi: 10.1046/j.1471-4159.2001.00332.x – volume: 32 start-page: 2757 year: 2011 ident: 10.1016/j.jpba.2014.10.009_bib0310 article-title: Analysis of chiral amino acids in cerebrospinal fluid samples linked to different stages of Alzheimer disease publication-title: Electrophoresis doi: 10.1002/elps.201100139 – volume: 29 start-page: 1961 year: 2004 ident: 10.1016/j.jpba.2014.10.009_bib0175 article-title: Biochemical aspects of neurodegeneration in human brain: involvement of neural membrane phospholipids and phospholipases A2 publication-title: Neurochem. Res. doi: 10.1007/s11064-004-6871-3 – volume: 26 start-page: 2342 year: 2010 ident: 10.1016/j.jpba.2014.10.009_bib0140 article-title: MetPA: a web-based metabolomics tool for pathway analysis and visualization publication-title: Bioinformatics doi: 10.1093/bioinformatics/btq418 – volume: 272 start-page: 4874 year: 2005 ident: 10.1016/j.jpba.2014.10.009_bib0230 article-title: 3-Hydroxyacyl-CoA dehydrogenase and short chain 3-hydroxyacyl-CoA dehydrogenase in human health and disease publication-title: FEBS J. doi: 10.1111/j.1742-4658.2005.04911.x – volume: 4 start-page: 189 year: 2004 ident: 10.1016/j.jpba.2014.10.009_bib0020 article-title: Metabonomics and its role in drug development and disease diagnosis publication-title: Expert Rev. Mol. Diagn. doi: 10.1586/14737159.4.2.189 – volume: 9 start-page: 974 year: 2013 ident: 10.1016/j.jpba.2014.10.009_bib0050 article-title: 1H NMR metabolomics investigation of an Alzheimer's disease (AD) mouse model pinpoints important biochemical disturbances in brain and plasma publication-title: Metabolomics doi: 10.1007/s11306-013-0516-y – volume: 1292 start-page: 93 year: 2009 ident: 10.1016/j.jpba.2014.10.009_bib0015 article-title: Age-related cognitive decline and nesting behavior in an APPswe/PS1 bigenic model of Alzheimer's disease publication-title: Brain Res. doi: 10.1016/j.brainres.2009.07.066 – volume: 56 start-page: 937 year: 2010 ident: 10.1016/j.jpba.2014.10.009_bib0055 article-title: A metabolomic study of the CRND8 transgenic mouse model of Alzheimer's disease publication-title: Neurochem. Int. doi: 10.1016/j.neuint.2010.04.001 – volume: 51 start-page: 660 year: 2010 ident: 10.1016/j.jpba.2014.10.009_bib0210 article-title: Quantitative analysis of phospholipids containing arachidonate and docosahexaenoate chains in microdissected regions of mouse brain publication-title: J. Lipid Res. doi: 10.1194/jlr.D001750 – volume: 29 start-page: 1423 year: 2008 ident: 10.1016/j.jpba.2014.10.009_bib0025 article-title: Age related changes in brain metabolites observed by 1H MRS in APP/PS1 mice publication-title: Neurobiol. Aging doi: 10.1016/j.neurobiolaging.2007.03.002 – volume: 71 start-page: 868 year: 2012 ident: 10.1016/j.jpba.2014.10.009_bib0280 article-title: Evidence for premature lipid raft aging in APP/PS1 double-transgenic mice, a model of familial Alzheimer disease publication-title: J. Neuropathol. Exp. Neurol. doi: 10.1097/NEN.0b013e31826be03c – volume: 14 start-page: 21021 year: 2013 ident: 10.1016/j.jpba.2014.10.009_bib0335 article-title: Impaired glutathione synthesis in neurodegeneration publication-title: Int. J. Mol. Sci. doi: 10.3390/ijms141021021 – volume: 235 start-page: 1 year: 2012 ident: 10.1016/j.jpba.2014.10.009_bib0035 article-title: Age-related changes in brain metabolites and cognitive function in APP/PS1 transgenic mice publication-title: Behav. Brain Res. doi: 10.1016/j.bbr.2012.07.016 – volume: 1 start-page: 617 year: 2012 ident: 10.1016/j.jpba.2014.10.009_bib0075 article-title: A dysregulated endocannabinoid-eicosanoid network supports pathogenesis in a mouse model of Alzheimer's disease publication-title: Cell Rep. doi: 10.1016/j.celrep.2012.05.001 – volume: 405 start-page: 5105 year: 2013 ident: 10.1016/j.jpba.2014.10.009_bib0100 article-title: Hippocampal metabolomics using ultrahigh-resolution mass spectrometry reveals neuroinflammation from Alzheimer's disease in CRND8 mice publication-title: Anal. Bioanal. Chem. doi: 10.1007/s00216-013-6825-1 – volume: 122 start-page: 271 year: 2011 ident: 10.1016/j.jpba.2014.10.009_bib0205 article-title: Peroxisomal alterations in Alzheimer's disease publication-title: Acta Neuropathol. doi: 10.1007/s00401-011-0836-9 – volume: 21 start-page: 331 year: 1987 ident: 10.1016/j.jpba.2014.10.009_bib0330 article-title: Amino acids, glutathione, and glutathione transferase activity in the brains of patients with Alzheimer's disease publication-title: Ann. Neurol. doi: 10.1002/ana.410210403 – volume: 135 start-page: 2970 year: 2010 ident: 10.1016/j.jpba.2014.10.009_bib0145 article-title: Direct infusion mass spectrometry or liquid chromatography mass spectrometry for human metabonomics? A serum metabonomic study of kidney cancer publication-title: Analyst doi: 10.1039/c0an00265h – volume: 309 start-page: 200 year: 2012 ident: 10.1016/j.jpba.2014.10.009_bib0155 article-title: Diagnosis of lung cancer based on direct-infusion electrospray mass spectrometry of blood plasma metabolites publication-title: Int. J. Mass Spectrom. doi: 10.1016/j.ijms.2011.10.002 – volume: 63 start-page: 395 year: 2001 ident: 10.1016/j.jpba.2014.10.009_bib0315 article-title: Role of spermine in amyloid β-peptide-associated free radical-induced neurotoxicity publication-title: J. Neurosci. Res. doi: 10.1002/1097-4547(20010301)63:5<395::AID-JNR1034>3.0.CO;2-Q – volume: 6 start-page: 156 year: 2010 ident: 10.1016/j.jpba.2014.10.009_bib0150 article-title: Metabolite profiling of blood plasma of patients with prostate cancer publication-title: Metabolomics doi: 10.1007/s11306-009-0187-x – volume: 10 start-page: 744 year: 2014 ident: 10.1016/j.jpba.2014.10.009_bib0215 article-title: Metabolic signatures of human Alzheimer's disease (AD): 1H NMR analysis of the polar metabolome of post-mortem brain tissue publication-title: Metabolomics doi: 10.1007/s11306-013-0610-1 – volume: 25 start-page: 52 year: 2012 ident: 10.1016/j.jpba.2014.10.009_bib0045 article-title: Effects of Alzheimer's disease transgenes on neurochemical expression in the mouse brain determined by 1H MRS in vitro publication-title: NMR Biomed. doi: 10.1002/nbm.1712 – volume: 71 start-page: 2034 year: 1998 ident: 10.1016/j.jpba.2014.10.009_bib0275 article-title: Increased nuclear DNA oxidation in the brain in Alzheimer's disease publication-title: J. Neurochem. doi: 10.1046/j.1471-4159.1998.71052034.x – volume: 3 start-page: 2364 year: 2013 ident: 10.1016/j.jpba.2014.10.009_bib0320 article-title: Metabolic profiling of Alzheimer's disease brains publication-title: Sci. Rep. doi: 10.1038/srep02364 – volume: 98 start-page: 321 year: 2014 ident: 10.1016/j.jpba.2014.10.009_bib0170 article-title: Metabolomic study of lipids in serum for biomarker discovery in Alzheimer's disease using direct infusion mass spectrometry publication-title: J. Pharm. Biomed. Anal. doi: 10.1016/j.jpba.2014.05.023 – volume: 22 start-page: 332 year: 2003 ident: 10.1016/j.jpba.2014.10.009_bib0125 article-title: Electrospray mass spectrometry of phospholipids publication-title: Mass Spectrom. Rev. doi: 10.1002/mas.10061 – volume: 32 start-page: 213 year: 2007 ident: 10.1016/j.jpba.2014.10.009_bib0305 article-title: Free amino acid and dipeptide changes in the body fluids from Alzheimer's disease subjects publication-title: Amino Acids doi: 10.1007/s00726-006-0409-8 – volume: 25 start-page: 1299 year: 2004 ident: 10.1016/j.jpba.2014.10.009_bib0180 article-title: Glycerophosphocholine is elevated in cerebrospinal fluid of Alzheimer patients publication-title: Neurobiol. Aging doi: 10.1016/j.neurobiolaging.2004.02.016 – volume: 10 start-page: 390 year: 2013 ident: 10.1016/j.jpba.2014.10.009_bib0235 article-title: Age-related mitochondrial alterations without neuronal loss in the hippocampus of a transgenic model of Alzheimer's disease publication-title: Curr. Alzheimer Res. doi: 10.2174/1567205011310040005 – volume: 199 start-page: 231 year: 2005 ident: 10.1016/j.jpba.2014.10.009_bib0345 article-title: Increased cerebrospinal fluid pyruvate levels in Alzheimer's disease publication-title: Neurosci. Lett. doi: 10.1016/0304-3940(95)12058-C |
SSID | ssj0005194 |
Score | 2.4021697 |
Snippet | •Direct infusion mass spectrometry allows a comprehensive brain metabolomic analysis.•The APP/PS1 mice exhibited an abnormal neurochemical profile compared to... The identification of pathological mechanisms underlying to Alzheimer's disease is of great importance for the discovery of potential markers for diagnosis and... |
SourceID | proquest pubmed crossref elsevier |
SourceType | Aggregation Database Index Database Enrichment Source Publisher |
StartPage | 425 |
SubjectTerms | Alzheimer Disease - genetics Alzheimer Disease - metabolism Alzheimer's disease Amyloid beta-Protein Precursor - genetics Animals APP/PS1 mice Brain - metabolism Brain regions Direct infusion mass spectrometry Disease Models, Animal Female Male Mass Spectrometry - methods Metabolomics Metabolomics - methods Mice Mice, Inbred C57BL Mice, Transgenic Presenilin-1 - genetics |
Title | Metabolomic screening of regional brain alterations in the APP/PS1 transgenic model of Alzheimer's disease by direct infusion mass spectrometry |
URI | https://dx.doi.org/10.1016/j.jpba.2014.10.009 https://www.ncbi.nlm.nih.gov/pubmed/25459942 https://www.proquest.com/docview/1652437689 https://www.proquest.com/docview/1660388210 |
Volume | 102 |
hasFullText | 1 |
inHoldings | 1 |
isFullTextHit | |
isPrint | |
link | http://utb.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwnV1NT9wwELUQXHqpWujHUoqmUkUPJWy8sZ3kuEKgbStQJEDiFtmxrS5adle72cNy6F_oX-6Mk0B7YA89xrIdKzPxvLFn3jD2OaksF8bqqJKpRgcltZHmNom8UT5TXMdaUYLzxaUa3Yjvt_J2i512uTAUVtnu_c2eHnbrtqXffs3-fDzuX6Fy8pQQgyASk5BRLkRKWn7y668wDx6KIVLniHq3iTNNjNfd3BD3EBcnIcIrf844PQc-gxE6f8VetugRhs0CX7MtN91lR0VDP70-huunbKrlMRxB8URMvd5jvy9cjTKfUCIy4HaBLiwaLph5oPIMBMnBUMUICFfozVEe4CNiRBgWRb-44lCTbUOlwxlCER0aPZw8_HTje7f4soT2wgfMGpovixP4FR3JwT3idAiZnUSRUC_Wb9jN-dn16ShqCzJEFTpGdZS5zJgBYjrjvZYyNbF0QhGDjdU5z7W3Rg2qFFFV4mPtufHKiUQPXBL7KkXg8JZtT2dT956BVcbGGdXNkoZu-HMr8so6GmgdvqDHeCeJsmrZyqloxqTswtLuSpJeSdKjNpRej319HDNvuDo29padgMt_NK5EY7Jx3KdOG0r8Fel-RU_dbLUsuZJE76iyjX0U8e-go91j7xpVelwr-uoyz8Vg_z9X9oG9wCcZDojkAduuFyv3ESFTbQ7DP3HIdobffowu_wCVSxge |
linkProvider | Elsevier |
linkToHtml | http://utb.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwnV1Lb9swDBaK9LBdhr2Xrds4YOgOqxcrtmT7GBQr0rUJDDQFehMkS8JSpEmQOIf0T-wvj_SjwQ7NYcc4oi2YtPhRIj8y9jUqLI-N1UEhEo0BSmIDzW0UeCN9KrkOtaQC59FYDq_jXzfi5oCdtrUwlFbZrP31ml6t1s2VXvM2e8vptHeFxskTQgwxkZhQRfkhsVOJDjscnF8Mx7tMD171Q6TxAQk0tTN1mtft0hD9EI9_VEle2WP-6TH8Wfmhs-fsWQMgYVDP8QU7cPOX7DivGai3JzDZFVStT-AY8h039fYV-zNyJap9RrXIgCsGRrHou2DhgTo0ECoHQ00joDpFr3fzAH8iTIRBnvfyKw4luTe0O7xD1UeHpAez-99ueudW39bQnPmA2UL9cvEGfkO7cnCHUB2q4k5iSShX29fs-uzn5HQYND0ZggJjozJIXWpMH2Gd8V4LkZhQuFgSiY3VGc-0t0b2iwSBVeRD7bnx0sWR7rso9EWC2OEN68wXc_eOgZXGhim1zhKGDvkzG2eFdSRoHT6gy3irCVU0hOXUN2Om2sy0W0XaU6Q9uoba67LvDzLLmq5j72jRKlj9Y3QK_cleuS-tNSj8GumIRc_dYrNWXApieJTp3jGSKHgw1u6yt7UpPcwVw3WRZXH__X_O7DN7MpyMLtXl-fjiA3uK_4hqv0gcsU652riPiKBK86n5Qv4CGqcazw |
openUrl | ctx_ver=Z39.88-2004&ctx_enc=info%3Aofi%2Fenc%3AUTF-8&rfr_id=info%3Asid%2Fsummon.serialssolutions.com&rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Ajournal&rft.genre=article&rft.atitle=Metabolomic+screening+of+regional+brain+alterations+in+the+APP%2FPS1+transgenic+model+of+Alzheimer%27s+disease+by+direct+infusion+mass+spectrometry&rft.jtitle=Journal+of+pharmaceutical+and+biomedical+analysis&rft.au=Gonz%C3%A1lez-Dom%C3%ADnguez%2C+Ra%C3%BAl&rft.au=Garc%C3%ADa-Barrera%2C+Tamara&rft.au=Vitorica%2C+Javier&rft.au=G%C3%B3mez-Ariza%2C+Jos%C3%A9+Luis&rft.date=2015-01-05&rft.pub=Elsevier+B.V&rft.issn=0731-7085&rft.eissn=1873-264X&rft.volume=102&rft.spage=425&rft.epage=435&rft_id=info:doi/10.1016%2Fj.jpba.2014.10.009&rft.externalDocID=S0731708514005007 |
thumbnail_l | http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/lc.gif&issn=0731-7085&client=summon |
thumbnail_m | http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/mc.gif&issn=0731-7085&client=summon |
thumbnail_s | http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/sc.gif&issn=0731-7085&client=summon |